Intracranial Aneurysm Market

Intracranial Aneurysm Market Size

The global intracranial aneurysm market was valued at USD 1.6 billion in 2025. The market is expected to reach from USD 1.8 billion in 2026 to USD 4 billion in 2035, growing at a CAGR of 9.1% during the forecast period, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to the technological advancements in minimally invasive neurovascular devices, increasing adoption of endovascular treatment over surgical clipping, and rising prevalence of intracranial aneurysms and associated risk factors, among other contributing factors.

An intracranial aneurysm is a confined, abnormal expansion or ballooning of a blood vessel in the brain caused by the thinning of the arterial wall. Such an aneurysm can grow gradually and is associated with the risk of its rupture, which may cause a bleeding situation in the area surrounding the brain that can be fatal. Typically, these aneurysms occur at branching points of major cerebral arteries.

The major players in the global intracranial aneurysm market are Johnson & Johnson, Medtronic, Stryker, MicroPort, and TERUMO. These firms keep their competitive position through continuous product innovation, worldwide market presence, and hefty investment in research and development.

The market has increased from USD 1.2 billion in 2022 and reached USD 1.5 billion in 2024, with the historic growth rate of 12.3%. The market growth was driven by technological advancements in endovascular devices, increasing awareness and early diagnosis of intracranial aneurysms, and the growing number of trained neurointerventional specialists performing minimally invasive procedures.

Moreover, the burden of intracranial aneurysms is rising globally, driven by factors such as hypertension, smoking, alcohol consumption, genetic predisposition, and an ageing population. For instance, according to the World Health Organization (WHO), approximately 1 in 4 adults worldwide had hypertension in 2021, a key risk factor for aneurysms.

The Centers for Disease Control and Prevention (CDC) also reported in 2022 that nearly 12.5% of U.S. adults were current smokers, further contributing to disease risk. As aneurysm incidence increases with age, the expanding elderly population intensifies the global case load; for example, the United Nations estimated in 2023 that the population aged 65 and above reached 761 million. Growing awareness among clinicians and patients has additionally accelerated diagnoses. Together, these trends have increased demand for screening, monitoring, and treatment solutions.

Furthermore, innovations such as flow-diverter stents, intrasaccular devices, advanced detachable coils, and next-generation microcatheters are transforming aneurysm management. These devices reduce procedure time, improve occlusion rates, and minimize complications. The shift toward minimally invasive neurointerventional procedures is expanding adoption worldwide. Continuous R&D by key players, significantly enhances clinical outcomes and market growth.

Intracranial Aneurysm Market Trends

The market is growing considerably with the rapid shift toward intrasaccular and flow-diverter technologies, increasing adoption of AI and advanced imaging for early detection, growing use of minimally invasive endovascular procedures, among other factors collectively driving industry growth.

• Flow-diversion devices and intrasaccular implants such as WEB and Contour are becoming more preferred than conventional coiling. These devices provide improved aneurysm occlusion, less retreatment, and better results in wide-neck or complex aneurysms. The transition is becoming faster due to a strong clinical evidence and more regulatory approvals.
  
• Endovascular procedures continue to replace surgical clipping as the standard of care. Technological improvements in coils, stents, and microcatheters are enabling treatment of previously inoperable aneurysms. Patient and clinician preference for lower-risk, faster-recovery procedures is driving this trend globally.
  
• Furthermore, major players such as Medtronic, Stryker, and TERUMO are speeding up clinical research to confirm the effectiveness of next-generation aneurysm devices. The number of trials focusing on long-term occlusion, safety, and treatment durability is increasing rapidly. The large R&D budget is the main reason for the continuous innovation and portfolio diversification by which the market growth is being sustained.
  

Intracranial Aneurysm Market Analysis

Based on the treatment type, the intracranial aneurysm market is segmented into endovascular coiling, surgical clipping, flow diverters, and other treatment types. The endovascular coiling segment has asserted its dominance in the market by securing a significant market share of 66.7% in 2025 owing to its minimally invasive nature, favourable clinical outcomes, and widespread adoption as the standard of care for both ruptured and unruptured aneurysms. The segment is expected to exceed USD 2.7 billion by 2035, growing at a CAGR of 9.2% during the forecast period.

On the other hand, the flow diverters segment is expected to grow with a CAGR of 9.7%. The growth of this segment is driven by increasing adoption of next-generation devices that offer superior long-term vessel reconstruction, reduced retreatment rates, and expanding use in complex and wide-neck aneurysms.

• The endovascular coiling segment continues to dominate the market. Endovascular coiling is generally preferred over surgical clipping, considering it is a less invasive method, entails a shorter recovery time, and has a lower procedural morbidity. Most notably, for elderly patients and those with a high surgical risk, this trend is very evident. As hospitals are moving towards minimally invasive care pathways, coiling cases keep on increasing.
  
• Long-term clinical trials provide evidence of fewer disabilities and better results of coiling in most cases as compared to open surgery. Coiling is being extensively recommended for both ruptured and unruptured aneurysms, also those in complicated areas. Procedural demand is getting higher due to updated guidelines and widening treatment indications.
  
• The surgical clipping segment held a revenue of USD 279.1 million in 2025, with projections indicating a steady expansion at 8.5% CAGR from 2026 to 2035. The segment is driven by its proven long-term durability, especially for aneurysms unsuitable for endovascular repair, and the growing availability of advanced intraoperative imaging and microsurgical tools that improve safety and precision during open procedures.
  
• The flow diverters segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 9.7% over the forecast period. Flow diverters are gaining momentum as they enable parent vessel reconstruction and effective treatment of large, fusiform, or wide-neck aneurysms, supported by expanding clinical approvals and growing preference for single-device, long-term solutions.
  

Based on end use, the intracranial aneurysm market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 65% in 2025 and is expected to reach USD 2.5 billion within the forecast period.

• Hospitals experience high patient inflow due to increasing cases of subarachnoid hemorrhage, ruptured aneurysms, and acute neurovascular emergencies. As the burden of hypertension, smoking, and ageing rises, more patients present with aneurysm-related complications. This drives greater need for hospital-based, immediate intervention capabilities.
  
• Hospitals offer neurosurgeons, neurointerventionalists, intensivists, and trained imaging specialists under one roof, enabling coordinated management of high-risk aneurysm cases. Their 24/7 emergency and critical care capability makes hospitals the primary site for ruptured aneurysm treatment. This integrated care model strengthens their dominance in the market.
  
• The ambulatory surgical centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 9.7% over the forecast period. A rising shift toward outpatient neurovascular care, supported by faster patient recovery, lower procedural costs, and improved minimally invasive techniques, is driving greater utilization of ambulatory surgical centers for selected aneurysm cases.
  

North America Intracranial Aneurysm Market

North America dominated the market with the highest market share of 41.7% in 2025.

• The U.S. intracranial aneurysm market was valued at USD 473.9 million and USD 531.8 million in 2022 and 2023, respectively. The market size reached USD 637.8 million in 2025, growing from USD 584.3 million in 2024, and is anticipated to grow at a CAGR of 7.9% between 2026 to 2035.
  
• North America is heavily affected by intracranial aneurysms, especially in older populations with high blood pressure and smoking habits, as well as other lifestyle risk factors. The increase in awareness and routine health screenings are leading to early detection, which, in turn, is increasing the demand for treatment solutions.
  
• In addition, the region is well-equipped with a network of comprehensive stroke centers, hybrid operating rooms, and advanced neurointerventional suites. These are some of the facilities that allow hospitals to perform a wide range of endovascular and surgical aneurysm procedures in a short time, thereby increasing the local market proliferation.
  

Europe Intracranial Aneurysm Market

Europe market accounted for USD 410.8 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Several European countries provide government-led programs to improve stroke and neurovascular care, including funding for advanced imaging and interventional procedures. Policy support for early detection and treatment encourages hospital investment in neurointerventional technologies, expanding market adoption.
  
• European neurosurgeons increasingly prefer coiling and flow-diverter stents over surgical clipping due to shorter recovery times and reduced complications. Hospitals are adopting endovascular-first strategies, supported by regional guidelines favouring less invasive interventions.
  

Asia Pacific Intracranial Aneurysm Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 10.6% during the analysis timeframe.

• Rapid economic growth in countries like China, India, Japan, and South Korea has led to significant investment in advanced hospitals and neurointerventional suites. Improved availability of hybrid ORs, angiography systems, and stroke centers supports higher procedure volumes for aneurysm treatment.
•  
• Further, the region is witnessing a steady increase in elderly populations, combined with rising hypertension, smoking, and diabetes prevalence. These factors contribute to a higher incidence of intracranial aneurysms, driving the need for timely intervention and management.
  

Latin America Intracranial Aneurysm Market

The Latin America market is experiencing robust growth over the analysis timeframe.

• In Latin America, the intracranial aneurysm market is driven by rising investments in healthcare infrastructure and the establishment of specialized neurointerventional centers in urban regions. Increasing prevalence of hypertension and lifestyle-related risk factors is contributing to higher aneurysm incidence.
  
• Growing adoption of advanced endovascular procedures, including coiling and flow diversion, is expanding treatment access. In addition, government initiatives and health programs aimed at improving stroke care are supporting early diagnosis and intervention.
  

Middle East & Africa Intracranial Aneurysm Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• The regional growth is driven by rapidly improving healthcare infrastructure and the establishment of modern neurointerventional centers in key cities. Rising awareness of stroke and aneurysm risks among patients and physicians is increasing demand for early diagnosis.
  
• Adoption of minimally invasive endovascular technologies is growing due to better clinical outcomes and shorter hospital stays. Additionally, government investments and public-private partnerships are enhancing access to advanced neurovascular treatments across the region.
  

Intracranial Aneurysm Market Share

The market is competitive, with several global and regional players focusing on product innovation, strategic collaborations, and geographic expansion to strengthen their market positions. Companies are investing heavily in research and development to introduce advanced endovascular devices such as flow-diverter stents, intrasaccular implants, and next-generation coils that offer higher efficacy and improved safety profiles. Key players include Johnson & Johnson, Medtronic, Stryker, MicroPort, and TERUMO, collectively accounting for 68.5% of the total market share.

Market players are also adopting strategies such as mergers and acquisitions, partnerships with hospitals, and clinical collaborations to expand their product portfolios and enhance market penetration. The focus on minimally invasive procedures, coupled with increasing adoption of advanced imaging technologies, is driving intense competition among manufacturers.

Additionally, emerging players in Asia Pacific and Latin America are leveraging cost-effective innovations to capture regional demand, further intensifying the competitive landscape and fuelling global market growth.

Intracranial Aneurysm Market Companies

A few of the prominent players operating in the intracranial aneurysm industry include:

• B. BRAUN
• Balt Group
• INTEGRA
• Johnson & Johnson
• Medtronic
• MicroPort
• MIZUYHO
• Penumbra
• Peter LAZIC
• phenox
• Shape Memory Medical
• Stryker
• TERUMO
• Wallaby Medical
• ZYLOX TONBRIDGE
  
• Johnson & Johnson

It offers a comprehensive neurovascular portfolio through Cerenovus, including coils, stents, and flow diverters, supported by strong clinical evidence and global physician training programs. Its integrated solutions enhance procedural efficiency and patient outcomes.

• Medtronic

Leverages a broad global distribution network and advanced neurovascular devices, including flow diverters and intrasaccular systems, backed by continuous R&D and surgeon education. This strengthens adoption across complex aneurysm cases worldwide.

• Stryker

Provides innovative surgical and endovascular solutions with a focus on minimally invasive technologies and precision-guided systems. Its emphasis on integrated imaging and procedural support enhances safety and efficacy in aneurysm interventions.

Intracranial Aneurysm Industry News:

• In October 2025, Kaneka Corporation announced that it had begun sales of its i-ED brain aneurysm embolisation coil in Europe. This launch expanded the availability of advanced endovascular treatment options, enhancing therapeutic choices for clinicians. It is also expected to strengthen the company’s presence in the European market, potentially driving market growth.
  
• In May 2023, Cerenovus, Inc., part of Johnson & Johnson, announced that its Cerepak detachable coils are commercially available in the U.S. This strategy helped the company to strengthen its position in the neurovascular devices industry and solidify its reputation as an innovative provider of solutions for hemorrhagic stroke treatment and intracranial aneurysm.
  
• In August 2022, MicroPort, received marketing approval issued for its independently developed Numen Coil Embolization System, by Ministry of Health, Labour and Welfare Japan, marking the first approved product in Japan for MicroPort NeuroTech. This approval generated high revenue for the company and enhanced its market presence.
  

The intracranial aneurysm market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Treatment Type

• Endovascular coiling
• Surgical clipping
• Flow diverters
• Other treatment types

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE